EP0861267 - INDUCING RESISTANCE TO TUMOR GROWTH WITH SOLUBLE IGF-1 RECEPTOR [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.06.2003 Database last updated on 27.07.2024 | Most recent event Tooltip | 20.06.2003 | Application deemed to be withdrawn | published on 06.08.2003 [2003/32] | Applicant(s) | For all designated states THOMAS JEFFERSON UNIVERSITY 1020 Walnut Avenue Philadelphia Pennsylvania 19107 / US | [N/P] |
Former [1998/36] | For all designated states THOMAS JEFFERSON UNIVERSITY 11th and Walnut Streets Philadelphia Pennsylvania 19107 / US | Inventor(s) | 01 /
BASERGA, Renato 125 Bleddyn Road Ardmore, PA 19003 / US | 02 /
RESNICOFF, Mariana Apartment 2617, 1500 Locust Street Philadelphia, PA 19102 / US | 03 /
D'AMBROSIO, Consuelo 1014 Spruce Street Philadelphia, PA 19107 / US | 04 /
FERBER, Andres 623 Lombard Street Philadelphia, PA 19147 / US | [1998/42] |
Former [1998/36] | 01 /
BASERGA, Renato 125 Bleddyn Road Ardmore, PA 19003 / US | ||
02 /
RESNICOFF, Mariana Apartment 2617, 1500 Locust Street Philadelphia, PA 19102 / US | |||
03 /
D'AMBROSIO, Consuelo 1014 Spruce Street Philadelphia, PA 19107 / US | |||
04 /
FERBER, Andre 623 Lombard Street Philadelphia, PA 19147 / US | Representative(s) | Hallybone, Huw George Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
Former [1998/36] | Hallybone, Huw George CARPMAELS AND RANSFORD 43 Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 96941358.2 | 13.11.1996 | [1998/36] | WO1996US18327 | Priority number, date | US19950006699P | 14.11.1995 Original published format: US 6699 P | [1998/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9718241 | Date: | 22.05.1997 | Language: | EN | [1997/22] | Type: | A1 Application with search report | No.: | EP0861267 | Date: | 02.09.1998 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.05.1997 takes the place of the publication of the European patent application. | [1998/36] | Search report(s) | International search report - published on: | US | 22.05.1997 | (Supplementary) European search report - dispatched on: | EP | 16.12.1999 | Classification | IPC: | C07K14/71, A61K38/17, A61K48/00, C12N5/10, C12N15/12 | [1998/36] | CPC: |
C07K14/71 (EP,US);
A61P35/00 (EP);
C07K14/72 (EP,US);
A61K38/00 (EP,US);
A61K48/00 (EP,US)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1998/36] | Title | German: | INDUKTION UND RESISTENZ GEGEN TUMORWACHSTUM MITTELS LOESLICHEM IGF-1 | [1998/36] | English: | INDUCING RESISTANCE TO TUMOR GROWTH WITH SOLUBLE IGF-1 RECEPTOR | [1998/36] | French: | METHODE POUR PROVOQUER UNE RESISTANCE A LA CROISSANCE DE TUMEURS AU MOYEN D'UN RECEPTEUR DE IGF-1 SOLUBLE | [1998/36] | Entry into regional phase | 04.06.1998 | National basic fee paid | 04.06.1998 | Search fee paid | 04.06.1998 | Designation fee(s) paid | 04.06.1998 | Examination fee paid | Examination procedure | 12.06.1997 | Request for preliminary examination filed International Preliminary Examining Authority: US | 04.06.1998 | Examination requested [1998/36] | 21.08.2002 | Despatch of a communication from the examining division (Time limit: M04) | 03.01.2003 | Application deemed to be withdrawn, date of legal effect [2003/32] | 06.03.2003 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2003/32] | Fees paid | Renewal fee | 04.06.1998 | Renewal fee patent year 03 | 12.11.1999 | Renewal fee patent year 04 | 28.11.2000 | Renewal fee patent year 05 | 14.11.2001 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 30.11.2002 | 07   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9423034 (CEDARS SINAI MEDICAL CENTER [US]) [X] 1-21 * the whole document *; | [A] - YAMASAKI H. ET AL., "Human insulin-like growth factor I receptor 950 tyrosine is required for somatotroph growth factor signal transduction", JOURNAL OF BIOLOGICAL CHEMISTRY, (1992), vol. 267, pages 20953 - 20958, XP000857347 [A] 1 | [A] - YAMASAKI H. ET AL., "Structure-function of the human insuline-like growth factor-I receptor: a discordance of somatotroph internalization and signaling", MOLECULAR ENDOCRINOLOGY, (1993), vol. 7, pages 681 - 685, XP000856912 [A] 1 DOI: http://dx.doi.org/10.1210/me.7.5.681 | [A] - YAMASAKI H. ET AL., "Binding and action of insulin-like growth factor I in pituitary tumor cells", ENDOCRINOLOGY, (1991), vol. 128, no. 2, pages 857 - 862, XP000856902 [A] 1-21 | International search | [Y]WO9117252 (NOVO NORDISK AS [DK]); | [A]US5262308 (BASERGA RENATO [US]); | [Y]WO9422486 (UNIV JEFFERSON [US], et al) | [Y] - THE EMBO JOURNAL, 1986, Vol. 5, No. 10, ULLRICH et al., "Insulin-like Growth Factor lambda Receptor Suggests Structural Determinants That Define Functional Specificity", pages 2503-2512. | [Y] - JOURNAL OF CELLULAR PHYSIOLOGY, 1991, Vol. 149, CAMPBELL P.G. et al., "Insulin-Like Growth Factor Binding Protein (IGFBP) Inhibits IGF Action on Human Osteosarcoma Cells", pages 293-300. |